Africa's Path to Vaccine Self-Sufficiency: New South African Plant Offers Hope Amidst Challenges
Business

Africa's Path to Vaccine Self-Sufficiency: New South African Plant Offers Hope Amidst Challenges

The African Development Bank (AfDB) has signed an agreement to support the construction of a new vaccine manufacturing facility in South Africa. This marks a significant step for the continent in reducing its reliance on imported vaccines and establishing health sovereignty. However, challenges remain in maintaining manufacturing capacity and efficiency, including skilled workforce development and long-term investment.

This article requires PRO

This article is outside the free access window or is a special report. PRO unlocks it and the full archive.